Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression-Reference-Cited by-同舟云学术

Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression

Published:2019-01 Issue: Volume:243 Page:116-120
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Rosenblat Joshua D.,Simon Gregory E.,Sachs Gary S.,Deetz Ingrid,Doederlein Allen,DePeralta Denisse,Dean Mary Mischka,McIntyre Roger S.

Funder

Novartis

Supernus Pharmaceuticals

Lundbeck

Pfizer

AstraZeneca

Elli-Lilly

JanssenOrtho

Purdue

Johnson & Johnson

Moksha8

Sunovion

Mitsubishi

Takeda

Otsuka

Shire

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference22 articles.

1. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy;Ahmed;Medical Care,2012

2. The patient-reported outcomes measurement information system (PROMIS);Cella;Medical Care,2007

3. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis;Cipriani;Lancet,2018

4. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report;Fava;The Am. J. Psychiatry,2008

5. Participants’ perspectives on safety monitoring in clinical trials;Flynn;Clinical Trials,2013

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of electroencephalography functional connectivity during emotional recognition among patients with major depressive disorder and healthy controls;Journal of Psychiatric Research;2024-02

2. The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study;Health Expectations;2024-01-09

3. Psychotropic Drug–Related Weight Gain and Its Treatment;American Journal of Psychiatry;2024-01-01

4. Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies;European Neuropsychopharmacology;2024-01

5. Assessing emotional blunting in a psychiatric population: Psychometric properties of the Swedish version of the Oxford Depression Questionnaire;Journal of Affective Disorders Reports;2023-12